Combined Rehabilitation with Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferolin Discogenic Sciatica in Young People: A Randomized Clinical Trial

被引:5
作者
Scaturro, Dalila [1 ]
Vitagliani, Fabio [2 ]
Tomasello, Sofia [3 ]
Sconza, Cristiano [4 ]
Respizzi, Stefano [4 ]
Letizia Mauro, Giulia [1 ]
机构
[1] Univ Palermo, Dept Surg Oncol & Stomatol Disciplines, I-90121 Palermo, Italy
[2] Univ Catania, Dept Biomed & Biotechnol Sci, I-95123 Catania, Italy
[3] Univ Palermo, Fac Med & Surg, I-90127 Palermo, Italy
[4] Human Clin & Res Ctr IRCSS, Dept Phys & Rehabil Med, I-20019 Milan, Italy
来源
MEDICINA-LITHUANIA | 2023年 / 59卷 / 12期
基金
英国科研创新办公室;
关键词
sciatica; rehabilitation; postural balance; alpha lipoic acid; acetyl-l-carnitine; LOW-BACK-PAIN; SUPEROXIDE-DISMUTASE; PERIPHERAL NEUROPATHY; METAANALYSIS; MANAGEMENT; DIAGNOSIS; DISC;
D O I
10.3390/medicina59122197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and Objectives: In the Western world, back pain and sciatica are among the main causes of disability and absence from work with significant personal, social, and economic costs. This prospective observational study aims to evaluate the effectiveness of a rehabilitation program combined with the administration of Alpha Lipoic Acid, Acetyl-L-Carnitine, Resveratrol, and Cholecalciferol in the treatment of sciatica due to herniated discs in young patients in terms of pain resolution, postural alterations, taking painkillers, and quality of life. Materials and Methods: A prospective observational study was conducted on 128 patients with sciatica. We divided the sample into 3 groups: the Combo group, which received a combination of rehabilitation protocol and daily therapy with 600 mg Alpha Lipoic Acid, 1000 mg Acetyl-L-Carnitine, 50 mg Resveratrol, and 800 UI Cholecalciferol for 30 days; the Reha group, which received only a rehabilitation protocol; and the Supplement group, which received only oral supplementation with 600 mg Alpha Lipoic Acid, 1000 mg Acetyl-L-Carnitine, 50 mg Resveratrol, and 800 UI Cholecalciferol. Clinical assessments were made at the time of recruitment (T0), 30 days after the start of treatment (T1), and 60 days after the end of treatment (T2). The rating scales were as follows: the Numeric Rating Scale (NRS); the Oswestry Disability Questionnaire (ODQ); and the 36-item Short Form Health Survey (SF-36). All patients also underwent an instrumental stabilometric evaluation. Results: At T1, the Combo group showed statistically superior results compared to the other groups for pain (p < 0.05), disability (p < 0.05), and quality of life (p < 0.05). At T2, the Combo group showed statistically superior results compared to the other groups only for pain (p < 0.05) and quality of life (p < 0.05). From the analysis of the stabilometric evaluation data, we only observed a statistically significant improvement at T2 in the Combo group for the average X (p < 0.05) compared to the other groups. Conclusions: The combined treatment of rehabilitation and supplements with anti-inflammatory, pain-relieving, and antioxidant action is effective in the treatment of sciatica and can be useful in improving postural stability.
引用
收藏
页数:10
相关论文
共 40 条
[1]   Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathy [J].
Bertolotto F. ;
Massone A. .
Drugs in R&D, 2012, 12 (1) :29-34
[2]   COMPARISON OF STATIC POSTURAL BALANCE BETWEEN HEALTHY SUBJECTS AND THOSE WITH LOW BACK PAIN [J].
Braga, Alice Bernardi ;
de Mello Alves Rodrigues, Ana Carolina ;
Moraes Pereira de Lima, Giliane Vanessa ;
de Melo, Larissa Rabello ;
de Carvalho, Alberito Rodrigo ;
Flor Bertolini, Gladson Ricardo .
ACTA ORTOPEDICA BRASILEIRA, 2012, 20 (04) :210-212
[3]   Proprioceptive weighting changes in persons with low back pain and elderly persons during upright standing [J].
Brumagne, S ;
Cordo, P ;
Verschueren, S .
NEUROSCIENCE LETTERS, 2004, 366 (01) :63-66
[4]   Persons with recurrent low back pain exhibit a rigid postural control strategy [J].
Brumagne, Simon ;
Janssens, Lotte ;
Knapen, Stefanie ;
Claeys, Kurt ;
Suuden-Johanson, Ege .
EUROPEAN SPINE JOURNAL, 2008, 17 (09) :1177-1184
[5]  
Checchia GA, 2017, EUR REV MED PHARMACO, V21, P1653
[6]   Diagnosis and treatment of low back pain: A joint clinical practice guideline from the American college of physicians and the American pain society [J].
Chou, Roger ;
Qaseem, Amir ;
Snow, Vincenza ;
Casey, Donald ;
Cross, J. Thomas, Jr. ;
Shekelle, Paul ;
Owens, Douglas K. .
ANNALS OF INTERNAL MEDICINE, 2007, 147 (07) :478-491
[7]  
Costantino M, 2014, EUR REV MED PHARMACO, V18, P2766
[8]   Opioids for low back pain [J].
Deyo, Richard A. ;
Von Korff, Michael ;
Duhrkoop, David .
BMJ-BRITISH MEDICAL JOURNAL, 2015, 350
[9]   Resveratrol Inhibition of the WNT/β-Catenin Pathway following Discogenic Low Back Pain [J].
Genovese, Tiziana ;
Impellizzeri, Daniela ;
D'Amico, Ramona ;
Cordaro, Marika ;
Peritore, Alessio Filippo ;
Crupi, Rosalia ;
Gugliandolo, Enrico ;
Cuzzocrea, Salvatore ;
Fusco, Roberta ;
Siracusa, Rosalba ;
Di Paola, Rosanna .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
[10]   Low-level laser therapy for chronic non-specific low back pain: a meta-analysis of randomised controlled trials [J].
Glazov, Gregory ;
Yelland, Michael ;
Emery, Jon .
ACUPUNCTURE IN MEDICINE, 2016, 34 (05) :328-341